Safety of Japanese encephalitis vaccines [PDF]
Human Vaccines & Immunotherapeutics, 2021 Japanese encephalitis (JE) is an endemic disease dominantly in the Asia-Pacific region with mortality rate varying between 3% and 30%. Long-term neuropsychiatric sequelae developed in 30–50% of the survivors.
Ya-Li Hu, Ping-Ing Lee
doaj +7 more sources
Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease [PDF]
Human Vaccines & Immunotherapeutics, 2017 Japanese encephalitis (JE) is a serious public health concern in most of Asia. The disease is caused by JE virus (JEV), a flavivirus transmitted by Culex mosquitoes.
Nagendra R. Hegde, Milind M. Gore
doaj +3 more sources
Recommendations for the use of Japanese encephalitis vaccines
Pediatrics and Neonatology, 2020 Japanese encephalitis (JE) is a mosquito-borne viral infection which is prevalent in Taiwan. The virus circulates in an enzootic cycle in pigs which serve as amplifying hosts. Outbreaks typically occur during summer. A universal vaccination program using
Ping-Ing Lee +15 more
doaj +2 more sources
Japanese Encephalitis Virus: An Update on the Potential Antivirals and Vaccines
Vaccines, 2023 Japanese encephalitis virus (JEV) is the causal agent behind Japanese encephalitis (JE), a potentially severe brain infection that spreads through mosquito bites.
Kumar Saurabh Srivastava +8 more
doaj +3 more sources
The Battle Between Japanese Encephalitis Virus and Host Innate Immune System: Evasion and Response [PDF]
VirusesJapanese encephalitis (JE) is a natural zoonotic disease caused by the Japanese encephalitis virus (JEV), which poses potential threats to human health and the pig farming industry.
Teng Liu +5 more
doaj +2 more sources
Epidemiology of Japanese encephalitis in the Philippines prior to routine immunization
International Journal of Infectious Diseases, 2021 Background: Findings were published in 2015 that highlighted the endemicity of Japanese Encephalitis (JE) in the Philippines. The policymakers responded by conducting an immunization campaign and strengthening the surveillance system.
Anna Lena Lopez +6 more
doaj +1 more source
Cost of Acute and Sequelae Care for Japanese Encephalitis Patients, Bangladesh, 2011–2021
Emerging Infectious Diseases, 2023 Japanese encephalitis (JE) is associated with an immense social and economic burden. Published cost-of-illness data come primarily from decades-old studies. To determine the cost of care for patients with acute JE and initial and long-term sequelae from
Rebeca Sultana +23 more
doaj +1 more source
Arboviral vaccines for use in pregnant travelers
Travel Medicine and Infectious Disease, 2023 Pregnant women traveling abroad can be exposed to a variety of arboviruses, primarily spread by mosquitoes or ticks. Some arboviral infections can be of particular concern for pregnant women or their fetuses.
S.L. Hills, J.M. Wong, J.E. Staples
doaj +1 more source
Genotype 5 Japanese Encephalitis Virus—Old Genotype, New Threat
Zoonoses, 2022 Japanese encephalitis (JE) is an important viral encephalitis with epidemic status in Asia, which is caused by Japanese encephalitis virus (JEV), a member of the genus Flavivirus . JEV is divided into five genotypes.
Weijia Zhang +3 more
doaj +1 more source
The reemerging and outbreak of genotypes 4 and 5 of Japanese encephalitis virus
Frontiers in Cellular and Infection Microbiology, 2023 The Japanese encephalitis virus (JEV) is classified into five distinct genotypes, with genotypes 1 and 3 historically showing higher activity. These genotypes are the primary agents of viral encephalitis in the Asian continent.
Weijia Zhang +3 more
doaj +1 more source